Quick Answer
GT Biopharma, Inc. reported Gross Profit of $0.00 for fiscal year 2017.
GT Biopharma, Inc. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2017 | $0.00 | — |
| 2016 | $0.00 | -100.0% |
| 2015 | $27.0K | +575.0% |
| 2014 | $4.0K | -97.2% |
| 2013 | $142.0K | -42.7% |
| 2012 | $248.0K | +1227.3% |
| 2011 | -$22.0K | +59.3% |
| 2010 | -$54.0K | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| March 31, 2020 | $0.00 | — | — |
| March 31, 2019 | $0.00 | — | — |
| June 30, 2018 | $0.00 | — | — |
| March 31, 2018 | $0.00 | — | — |
| September 30, 2017 | $0.00 | — | — |
| June 30, 2017 | $0.00 | — | — |
| March 31, 2017 | $0.00 | — | — |
| September 30, 2016 | $0.00 | — | — |
- Over the 2010–2017 period, GT Biopharma, Inc.’s gross profit has grown by 100.0% (from -$54.0 thousand to $0.00).
- The most recent figure is from GT Biopharma, Inc.’s fiscal year 2017 report (Form 10-K), filed with the SEC on March 1, 2018.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: